CTC在结直肠癌临床应用中的研究进展
摘要
依赖于结肠镜检查及组织活检，这些传统方法虽然精准，但存在一定的侵入性和风险，可能导致患者不适或并发症。
循环肿瘤细胞（CTC）作为 CRC早期诊断、筛查、治疗监测和预后预测的重要工具，已经在多个临床研究中表现出
其独特的应用潜力。本文对 CTC的技术进展及 CTC在结直肠癌中多方面的临床应用进行综述。
关键词
全文:
PDF参考
[1]张书婧，周庆红，姜伟，等.结直肠癌生物标志
物在诊断和预后中的应用：现状与未来展望 [J].环境与健
康 杂 志，2024，41（11）：1024-1028.DOI：10.16241/
j.cnki.1001-5914.2024.11.018.
[2]Markou A, Tzanikou E, Lianidou E. The potential
of liquid biopsy in the management of cancer patients[C]//
Seminars in cancer biology. Academic Press, 2022, 84: 69-79.
[3]Micalizzi D S, Maheswaran S, Haber D A. A conduit
to metastasis: circulating tumor cell biology[J]. Genes &
development, 2017, 31(18): 1827-1840.
[4]Millner L M, Linder M W, Valdes R. Circulating
tumor cells: a review of present methods and the need to
identify heterogeneous phenotypes[J]. Annals of Clinical &
Laboratory Science, 2013, 43(3): 295-304.
[5]Alix-Panabières C, Pantel K. Clinical applications of
circulating tumor cells and circulating tumor DNA as liquid
biopsy[J]. Cancer discovery, 2016, 6(5): 479-491.
[6]Luo Q, Wang C, Peng B, et al. Circulating tumor_xfffe_cell-associated white blood cell clusters in peripheral blood
indicate poor prognosis in patients with hepatocellular
carcinoma[J]. Frontiers in Oncology, 2020, 10: 1758.
[7]Zhu S, Jiang F, Han Y, et al. Microfluidics for label_xfffe_free sorting of rare circulating tumor cells[J]. Analyst, 2020,
73
现代医学前沿 | 第2卷/第11期
Advances in Mordern Medical
145(22): 7103-7124.
[8]Qian W, Zhang Y, Chen W. Capturing cancer:
emerging microfluidic technologies for the capture and
characterization of circulating tumor cells[J]. Small, 2015,
11(32): 3850-3872.
[9]Jiang Y, Chen J, Xuan W, et al. Numerical study
of particle separation through integrated multi-stage surface
acoustic waves and modulated driving signals[J]. Sensors,
2023, 23(5): 2771.
[10]Gleghorn J P, Pratt E D, Denning D, et al. Capture
of circulating tumor cells from whole blood of prostate
cancer patients using geometrically enhanced differential
immunocapture (GEDI) and a prostate-specific antibody[J].
Lab on a Chip, 2010, 10(1): 27-29.
[11]Casavant B P, Mosher R, Warrick J W, et al. A
negative selection methodology using a microfluidic platform
for the isolation and enumeration of circulating tumor cells[J].
Methods, 2013, 64(2): 137-143.
[12]Nonaka T, Wong D T W. Saliva diagnostics[J].
Annual Review of Analytical Chemistry, 2022, 15(1): 107-
121.
[13]Liu H, Wang Z, Chen C, et al. Dual-antibody
Modified PLGA Nanofibers for Specific Capture of Epithelial
and Mesenchymal CTCs[J]. Colloids and Surfaces B:
Biointerfaces, 2019, 181: 143-148.
[14 ]Min L, W ang B, B ao H, et al. A dv ance d
nanotechnologies for extracellular vesicle‐based liquid
biopsy[J]. Advanced Science, 2021, 8(20): 2102789.
[15 ]Liu H, Liu X, Meng J, et al. Hydrophobic
interaction‐mediated capture and release of cancer cells
on thermoresponsive nanostructured surfaces[J]. Advanced
Materials, 2013, 25(6): 922-927.
[16]Adler A, Geiger S, Keil A, et al. Improving
compliance to colorectal cancer screening using blood and
stool based tests in patients refusing screening colonoscopy in
Germany[J]. BMC gastroenterology, 2014, 14: 1-8.
[17]Tsai W S, You J F, Hung H Y, et al. Novel circulating
tumor cell assay for detection of colorectal adenomas and
cancer[J]. Clinical and translational gastroenterology, 2019,
10(10): e00088.
[18]Kim H J, Choi C H, Lee Y Y, et al. Surgical
outcome prediction in patients with advanced ovarian
cancer using computed tomography scans and intraoperative
findings[J]. Taiwanese Journal of Obstetrics and Gynecology,
2014, 53(3): 343-347.
[19]Tan Y, Wu H. The significant prognostic value
of circulating tumor cells in colorectal cancer: A systematic
review and meta-analysis[J]. Current Problems in Cancer,
2018, 42(1): 95-106.
[20]De Rubis G, Krishnan S R, Bebawy M. Liquid
biopsies in cancer diagnosis, monitoring, and prognosis[J].
Trends in pharmacological sciences, 2019, 40(3): 172-186.
[21]Ren L, Zhong X, Liu W, et al. Clinical significance
of a circulating tumor cell-based classifier in stage IB lung
adenocarcinoma: a multicenter, cohort study[J]. Annals of
Surgery, 2023, 277(2): e439-e448.
[22]Huang Z, Zhang Z, Zhou C, et al. Epithelial–
mesenchymal transition: The history, regulatory mechanism,
and cancer therapeutic opportunities[J]. MedComm, 2022,
3(2): e144.
[23]Zhao R, Cai Z, Li S, et al. Expression and clinical
relevance of epithelial and mesenchymal markers in circulating
tumor cells from colorectal cancer[J]. Oncotarget, 2017, 8(6):
9293.
[24 ]Lamouille S, Xu J, De rynck R. Molecula r
mechanisms of epithelial–mesenchymal transition[J]. Nature
reviews Molecular cell biology, 2014, 15(3): 178-196.
[25]Scully O J, Bay B H, Yip G, et al. Breast cancer
metastasis[J]. Cancer genomics & proteomics, 2012, 9(5):
311-320.
Refbacks
- 当前没有refback。
